Report Feature
The future of the global nanobiotechnology market looks promising with opportunities in pharmaceuticals, medical devices, and medical research. The global nanobiotechnology market is expected to grow with a CAGR of XX% from 2020 to 2025. The major drivers for this market are increasing prevalence of chronic diseases, rising demand for nanobiotechnology in stem cell therapy, and increasing applications of nanobiotechnology.
Emerging trends, which have a direct impact on the dynamics of the industry, include growing adoption of microfabrication for development of miniature biological system and introduction of advanced technologies for treatment of several acute aliments.
A total of XX figures / charts and XX tables are provided in this more than 150-page report to help in your business decisions. Sample figures with some insights are shown below. To learn the scope, benefits, companies researched, and other details of the global nanobiotechnology market report, please download the report brochure.
In this market, pharmaceuticals is the largest application of nanobiotechnology. Growth in various segments of the nanobiotechnology market are given below:
The study includes trends and forecast for the global nanobiotechnology market by application, therapeutics, and region as follows:
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
- Pharmaceuticals
- Medical Devices
- Medical Research
- Others
By Therapeutics [Value ($ Million) shipment analysis for 2014 – 2025]:
- Dental Therapies
- Cardiac Therapies
- Orthopedic Therapies
- Others
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
-
North America
- United States
- Canada
- Mexico
-
Europe
- United Kingdom
- Germany
- France
-
Asia Pacific
- China
- India
- Japan
-
The Rest of the World
- Brazil
Some of the nanobiotechnology companies profiled in this report include Aduro BioTech, Calando Pharmaceuticals, Biosante Phosphate Pharmaceuticals, Celgene, Elan Pharmaceuticals, Flamel Technologies, Nanophase Technologies, Sigma Aldrich, Dendritic Nanotechnologies, and SkyePharma Pharmaceuticals.
Lucintel forecasts that pharmaceuticals will remain the largest segment by application over the forecast period due to increase in expenditure in pharmaceutical and sector.
North America will remain the largest region over the forecast period due to presence of advanced healthcare facilities and infrastructure that can easily adopt nanobiotechnology.
|
Features of the Global Nanobiotechnology Market |
|
|
This report answers following key questions |
|
Q.1 What are some of the most promising potential, high-growth opportunities for the global nanobiotechnology market by application (pharmaceuticals, medical devices, medical research, and others), therapeutics (dental therapies, cardiac therapies, orthopedic therapies, and others), and region (North America, Europe, Asia Pacific, and Rest of the World)? Q.2 Which segments will grow at a faster pace and why? Q.3 Which region will grow at a faster pace and why? Q.4 What are the key factors affecting market dynamics? What are the drivers and challenges of the global nanobiotechnology market? Q.5 What are the business risks and threats to the global nanobiotechnology market? Q.6 What are the emerging trends in this nanobiotechnology market and the reasons behind them? Q.7 What are some changing demands of customers in this nanobiotechnology market? Q.8 What are the new developments in this nanobiotechnology market? Which companies are leading these developments? Q.9 Who are the major players in this nanobiotechnology market? What strategic initiatives are being implemented by key players for business growth? Q.10 What are some of the competitive products and processes in this nanobiotechnology market, and how big of a threat do they pose for loss of market share via material or product substitution? Q.11 What M&A activities did take place in the last five years in the global nanobiotechnology market? |
Report Scope
| Key Features | Description |
| Base Year for Estimation | 2019 |
|
Trend Period (Actual Estimates) |
2014-2019 |
| Forecast Period | 2020-2025 |
| Pages | More than 150 |
| Market Representation / Units | Revenue in US $ Million |
| Report Coverage | Market Trends & Forecasts, Competitor Analysis, New Product Development, Company Expansion, Merger, Acquisitions & Joint Venture, and Company Profiling |
| Market Segments | Application (Pharmaceuticals, Medical Devices, Medical Research, and Others) and Therapeutics (Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others) |
Regional Scope |
North America (USA, Mexico, and Canada), Europe (United Kingdom, Germany, and France), Asia (China, India, and Japan), and ROW (Brazil) |
| Customization | 10% Customization without Any Additional Cost |
Table of Contents
1. Executive Summary
3.1 Macroeconomic Trends and Forecast
3.2 Global Nanobiotechnology Market Trends and Forecast
4.1 Global Nanobiotechnology Market by Region
4.2.1 Market by Application: Pharmaceuticals, Medical Devices, Medical Research, and Others
4.2.2 Market by Therapeutics: Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others
4.2.3 Market by Species: Fish, Crustaceans, and Mollusks
4.2.4 The United States Nanobiotechnology Market
4.2.5 The Canadian Nanobiotechnology Market
4.2.6 The Mexican Nanobiotechnology Market
4.3.1 Market by Application: Pharmaceuticals, Medical Devices, Medical Research, and Others
4.3.2 Market by Therapeutics: Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others
4.3.3 The Nanobiotechnology Market of United Kingdom
4.3.4 The German Nanobiotechnology Market
4.3.5 The French Nanobiotechnology Market
4.4.1 Market by Application: Pharmaceuticals, Medical Devices, Medical Research, and Others
4.4.2 Market by Therapeutics: Dental Therapies, Cardiac Therapies, Orthopedic Therapies, and Others
4.4.3 The Chinese Nanobiotechnology Market
4.4.4 The Indian Nanobiotechnology Market
4.4.5 The Japanese Nanobiotechnology Market
8.1 Aduro BioTech
8.2 Calando Pharmaceuticals Inc.
8.3 Biosante Phosphate Pharmaceuticals Inc..
8.4 Celgene Corporation
8.5 Elan Pharmaceuticals Inc.
8.6 Flamel Technologies Inc.
8.7 Nanophase Technologies Corporation
8.8 Sigma Aldrich Company
8.9 Dendritic Nanotechnologies Inc.
8.10 SkyePharma Pharmaceuticals
Methodology
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in this market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Buy Now
Choose a license that fits your team. Instant PDF delivery.
Prices exclude taxes. Instant delivery. Custom licensing available on request.
